The effect of clomiphene citrate on different sperm parameters and serum hormone levels in preselected infertile men: a controlled double-blind cross-over study

Int J Androl. 1980 Oct;3(5):479-86. doi: 10.1111/j.1365-2605.1980.tb00136.x.

Abstract

In order to try to clarify the often supposed stimulating effect of clomiphene citrate on spermatogenesis a controlled double-blind cross-over trial was used. 30 pre-selected normogonadotropic infertile men were given 50 mg clomiphene citrate daily or placebo in a double-blind cross-over fashion for three months, each treatment period being separated by three to four months. On clomiphene treatment the median sperm count increased from 13.3 to 28.7 mill/ml (P < 0.001). During the placebo treatment schedules the median sperm count remained unchanged (P < 0.05). The increases of FSH, LH, testosterone, and oestradiol were highly significant (P < 0.001) during the clomiphene treatment but during placebo treatment the median hormone levels did not change (P < 0.05). Three pregnancies occurred due to clomiphene treatment and one occurred during placebo treatment.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Clinical Trials as Topic
  • Clomiphene / analogs & derivatives*
  • Clomiphene / therapeutic use
  • Double-Blind Method
  • Estradiol / blood
  • Follicle Stimulating Hormone / blood
  • Humans
  • Infertility, Male / blood
  • Infertility, Male / drug therapy*
  • Luteinizing Hormone / blood
  • Male
  • Placebos
  • Sperm Count
  • Spermatogenesis / drug effects*
  • Testosterone / blood

Substances

  • Placebos
  • Clomiphene
  • Testosterone
  • Estradiol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone